Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Bristol-Myers Squibb (BMS),Australian & New Zealand Urogenital and Prostate Cancer Trials Group Limited (ANZUP)
Scientific Title
A Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma